DiaMedica Therapeutics | 8-K: DiaMedica Therapeutics Provides a Business Update and Announces Second Quarter 2024 Financial Results
DiaMedica Therapeutics | S-3: Registration statement for specified transactions by certain issuers
DiaMedica Therapeutics | 8-K: Current report
DiaMedica Therapeutics | 8-K: Current report
DiaMedica Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
DiaMedica Therapeutics | 8-K: Current report
DiaMedica Therapeutics | 8-K: DiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2024 Financial Results
DiaMedica Therapeutics | 8-K: Current report
DiaMedica Therapeutics | DEFA14A: Others
DiaMedica Therapeutics | DEF 14A: Definitive information statements
DiaMedica Therapeutics | S-3: Registration statement for specified transactions by certain issuers
DiaMedica Therapeutics | 8-K: Current report
DiaMedica Therapeutics | 8-K: DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2023 Financial Results
DiaMedica Therapeutics | 8-K: Current report
DiaMedica Therapeutics | 8-K: DiaMedica Therapeutics Provides a Business Update and Announces Second Quarter 2023 Financial Results
DiaMedica Therapeutics | S-3: Registration statement for specified transactions by certain issuers
DiaMedica Therapeutics | 8-K: Current report
DiaMedica Therapeutics | 8-K: Current report
DiaMedica Therapeutics | 8-K: Current report
DiaMedica Therapeutics | 8-K: Current report
No Data
No Data